100% Quality Guarantee
PhD-Level Technical Support
Retinoblastoma Phospho-Ser807 Colorimetric Cell-Based ELISA Kit
Key Features

Retinoblastoma (Phospho-Ser807)Colorimetric Cell-Based ELISA Kit (CBCAB00483)

SKU CBCAB00483
Product Type ELISA Kit
ELISA Type Cell Based Phospho Specific
Research Area Cell Cycle
Reactivity Human
Reactivity Mouse
Reactivity Rat
Detection Method Colorimetric
€990

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetMSDS

Retinoblastoma (Phospho-Ser807)Colorimetric Cell-Based ELISA Kit

The Retinoblastoma Phospho-Ser807 Colorimetric Cell-Based ELISA Kit is a specialized assay designed for the precise quantification of phospho-ser807 levels in retinoblastoma cells. This kit offers exceptional sensitivity and accuracy, ensuring trustworthy and replicable results, making it the perfect tool for diverse research purposes.Phospho-ser807 is a key phosphorylation site on the retinoblastoma protein, playing a critical role in regulating cell cycle progression and cell growth.

Dysregulation of this phosphorylation site is associated with various cancer types, including retinoblastoma, making it a crucial target for studying cancer development and potential therapeutic interventions.With its advanced technology and user-friendly protocols, the Retinoblastoma Phospho-Ser807 Colorimetric Cell-Based ELISA Kit is an indispensable tool for researchers investigating retinoblastoma pathogenesis and exploring novel treatment strategies.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose